Literature DB >> 23100928

Chronic eosinophilic leukemia: a case report and review of literature.

Ashutosh Kumar1, Swasti Sinha, Anil Kumar Tripathi.   

Abstract

Chronic Eosinophilic Leukemia (CEL) is a rare type of chronic myeloproliferative disorder of unknown etiology with no available true incidence. The vaguely overlapping clinico - pathological picture of CEL with idiopathic hypereosinophilic syndrome (IHES) often adds to the diagnostic confusion. An evidence of genetic clonality of eosinophils or an increase in blast cells in the blood or bone marrow is mandatory for diagnosis of CEL while no specific diagnostic tests exist for IHES; making it an entity of exclusion. Till date, CEL is a rarely reported entity in India. We add yet another case of eosinophilic leukemia along with review of available literature.

Entities:  

Keywords:  Chronic eosinophilic leukemia; Idiopathic Hypereosinophilic syndrome

Year:  2008        PMID: 23100928      PMCID: PMC3453119          DOI: 10.1007/s12288-008-0010-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  17 in total

1.  EOSINOPHILIC LEUKEMIA AND DISSEMINATED EOSINOPHILIC COLLAGEN DISEASE--A DISEASE ENTITY?

Authors:  B ODEBERG
Journal:  Acta Med Scand       Date:  1965-02

Review 2.  Eosinophilia: secondary, clonal and idiopathic.

Authors:  Ayalew Tefferi; Mrinal M Patnaik; Animesh Pardanani
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 3.  Eosinophil function and disorders.

Authors:  D Zucker-Franklin
Journal:  Adv Intern Med       Date:  1974

4.  Eosinophilic leukemia. Report of five cases and review of literature.

Authors:  D S Benvenisti; J E Ultmann
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

5.  Eosinophilic leukemia with fibrosing endocarditis and short Y chromosome.

Authors:  E P Flannery; D E Dillon; M V Freeman; J D Levy; U D'Ambrosio; J L Bedynek
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

Review 6.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

7.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  Eosinophilic leukaemia: morphological, cytochemical, and electron microscopic studies.

Authors:  B Presentey; Z Jerushalmy; U Mintz
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

9.  Eosinophilic colitis as a complication of the hypereosinophilic syndrome.

Authors:  A M Shah; M Joglekar
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

10.  Hypereosinophilic syndrome.

Authors:  C Venkatesh; E Mahender; S Janani; S Malathi; M Vijayakumar; B R Nammalwar
Journal:  Indian J Pediatr       Date:  2006-03       Impact factor: 5.319

View more
  3 in total

1.  FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India.

Authors:  Anıl N Kumar; Vishwanath Sathyanarayanan; Visweswariah Lakshmi Devi; Namratha N Rajkumar; Umesh Das; Sarjana Dutt; Lakshmaiah K Chinnagiriyappa
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

2.  Chronic Eosinophilic Leukemia Presenting Predominantly with Cutaneous Manifestations.

Authors:  Suja Vidyadharan; Bebisha Joseph; Sukumaran Pradeep Nair
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

Review 3.  A review of current knowledge of myeloproliferative disorders in the horse.

Authors:  Katy Satué; Juan Carlos Gardon; Ana Muñoz
Journal:  Acta Vet Scand       Date:  2021-02-23       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.